152 related articles for article (PubMed ID: 25196441)
1. Efficacy of a new multifunctional surfactant-based biomaterial dressing with 1% silver sulphadiazine in chronic wounds.
Zölß C; Cech JD
Int Wound J; 2016 Oct; 13(5):738-43. PubMed ID: 25196441
[TBL] [Abstract][Full Text] [Related]
2. New Surfactant-based Dressing Product to Improve Wound Closure Rates of Nonhealing Wounds: A European Multicenter Study Including 1036 Patients.
Palumbo FP; Harding KG; Abbritti F; Bradbury S; Cech JD; Ivins N; Klein D; Menzinger G; Meuleneire F; Seratoni S; Zölß C; Mayer D
Wounds; 2016 Jul; 28(7):233-40. PubMed ID: 27428718
[TBL] [Abstract][Full Text] [Related]
3. A silver sulphadiazine-impregnated lipidocolloid wound dressing to treat second-degree burns.
Carsin H; Wassermann D; Pannier M; Dumas R; Bohbot S
J Wound Care; 2004 Apr; 13(4):145-8. PubMed ID: 15114825
[TBL] [Abstract][Full Text] [Related]
4. Use of Urgotul SSD to reduce bacteria and promote healing in chronic wounds.
Downe A
Br J Community Nurs; 2013 Mar; Suppl():S32, S34-8. PubMed ID: 23682500
[TBL] [Abstract][Full Text] [Related]
5. The wound-healing effects of a next-generation anti-biofilm silver Hydrofiber wound dressing on deep partial-thickness wounds using a porcine model.
Davis SC; Li J; Gil J; Valdes J; Solis M; Higa A; Bowler P
Int Wound J; 2018 Oct; 15(5):834-839. PubMed ID: 29893025
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG; Martyn-St James M; Richardson R
Cochrane Database Syst Rev; 2013 Dec; (12):CD003557. PubMed ID: 24363048
[TBL] [Abstract][Full Text] [Related]
7. A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model.
Yang Q; Larose C; Della Porta AC; Schultz GS; Gibson DJ
Int Wound J; 2017 Apr; 14(2):408-413. PubMed ID: 27212453
[TBL] [Abstract][Full Text] [Related]
8. Clinical experiences of using a silver hydroalginate dressing in Austria, Switzerland and Germany.
Kammerlander G; Afarideh R; Baumgartner A; Berger M; Fischelmayer K; Hirschberger G; Hangler W; Huber A; Kramml M; Locherer E; Scandella C; Süss-Burkhard A; Wipplinger P
J Wound Care; 2008 Sep; 17(9):384, 386-8. PubMed ID: 18833896
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.
Muangman P; Pundee C; Opasanon S; Muangman S
Int Wound J; 2010 Aug; 7(4):271-6. PubMed ID: 20528992
[TBL] [Abstract][Full Text] [Related]
10. Microbial cellulose dressing compared with silver sulphadiazine for the treatment of partial thickness burns: A prospective, randomised, clinical trial.
Aboelnaga A; Elmasry M; Adly OA; Elbadawy MA; Abbas AH; Abdelrahman I; Salah O; Steinvall I
Burns; 2018 Dec; 44(8):1982-1988. PubMed ID: 30005989
[TBL] [Abstract][Full Text] [Related]
11. The role of silver sulphadiazine in the conservative treatment of partial thickness burn wounds: A systematic review.
Heyneman A; Hoeksema H; Vandekerckhove D; Pirayesh A; Monstrey S
Burns; 2016 Nov; 42(7):1377-1386. PubMed ID: 27126813
[TBL] [Abstract][Full Text] [Related]
12. The role of alternative therapy in the management of partial thickness burns of the face--experience with the use of moist exposed burn ointment (MEBO) compared with silver sulphadiazine.
Ang ES; Lee ST; Gan CS; See P; Chan YH; Ng LH; Machin D
Ann Acad Med Singap; 2000 Jan; 29(1):7-10. PubMed ID: 10748957
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of Silver Sulfadiazine with other materials for healing and infection prevention in burns: A systematic review and meta-analysis.
Nímia HH; Carvalho VF; Isaac C; Souza FÁ; Gemperli R; Paggiaro AO
Burns; 2019 Mar; 45(2):282-292. PubMed ID: 29903603
[TBL] [Abstract][Full Text] [Related]
14. Reduction in skin grafting after the introduction of hydrofiber dressings in partial thickness burns: a comparison between a hydrofiber and silver sulphadiazine.
Dokter J; Boxma H; Oen IM; van Baar ME; van der Vlies CH
Burns; 2013 Feb; 39(1):130-5. PubMed ID: 22480921
[TBL] [Abstract][Full Text] [Related]
15. In vitro cellular viability studies on a concentrated surfactant-based wound dressing.
Chen R; Salisbury AM; Percival SL
Int Wound J; 2019 Jun; 16(3):703-712. PubMed ID: 30895731
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial of Hydrofiber dressing with silver versus povidone-iodine gauze in the management of open surgical and traumatic wounds.
Jurczak F; Dugré T; Johnstone A; Offori T; Vujovic Z; Hollander D;
Int Wound J; 2007 Mar; 4(1):66-76. PubMed ID: 17425549
[TBL] [Abstract][Full Text] [Related]
17. An open, parallel, randomized, comparative, multicenter study to evaluate the cost-effectiveness, performance, tolerance, and safety of a silver-containing soft silicone foam dressing (intervention) vs silver sulfadiazine cream.
Silverstein P; Heimbach D; Meites H; Latenser B; Mozingo D; Mullins F; Garner W; Turkowski J; Shupp J; Glat P; Purdue G
J Burn Care Res; 2011; 32(6):617-26. PubMed ID: 21979855
[TBL] [Abstract][Full Text] [Related]
18. A real-life clinical evaluation of a next-generation antimicrobial dressing on acute and chronic wounds.
Walker M; Metcalf D; Parsons D; Bowler P
J Wound Care; 2015 Jan; 24(1):11-22. PubMed ID: 25543819
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns.
Opasanon S; Muangman P; Namviriyachote N
Int Wound J; 2010 Dec; 7(6):467-71. PubMed ID: 20860635
[TBL] [Abstract][Full Text] [Related]
20. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
Boekema BK; Pool L; Ulrich MM
Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
